Guardian Pharmacy Services, Stock Today
| GRDN Stock | 24.94 0.02 0.08% |
Performance21 of 100
| Odds Of DistressLess than 24
|
Guardian Pharmacy is selling at 24.94 as of the 30th of November 2024; that is 0.08% down since the beginning of the trading day. The stock's open price was 24.96. Guardian Pharmacy has about a 24 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat solid performance during the last 90 days. Equity ratings for Guardian Pharmacy Services, are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
IPO Date 26th of September 2024 | Category Healthcare |
Guardian Pharmacy is entity of United States. It is traded as Stock on NYSE exchange. More on Guardian Pharmacy Services,
Moving together with Guardian Stock
Moving against Guardian Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Guardian Stock Highlights
| President CEO | Fred Burke | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Retail, Medical Care Facilities, Healthcare, Medical Care Facilities, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Guardian Pharmacy can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Guardian Pharmacy's financial leverage. It provides some insight into what part of Guardian Pharmacy's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Guardian Pharmacy Services, (GRDN) is traded on New York Stock Exchange in USA. It is located in 300 Galleria Parkway SE, Atlanta, GA, United States, 30339 and employs 10 people. Guardian Pharmacy is listed under Retail category by Fama And French industry classification. The company conducts business under Healthcare sector and is part of Medical Care Facilities industry.
Guardian Pharmacy generates positive cash flow from operations, but has no cash available
Check Guardian Pharmacy Probability Of Bankruptcy
Guardian Pharmacy Historical Income Statement
Guardian Stock Against Markets
Guardian Pharmacy Corporate Management
| Douglas Towns | VP Counsel | Profile | |
| David Martin | Vice Officer | Profile | |
| Bethany RPh | Senior Marketing | Profile | |
| Kendall RPh | Executive Operations | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardian Pharmacy Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.